Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate

    • Product Name: tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate
    • Chemical Name (IUPAC): tert-butyl 2-[(4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
    • CAS No.: 1419422-42-4
    • Chemical Formula: C13H21NO4
    • Form/Physical State: Liquid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 373238
    Product Name tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate
    Molecular Formula C14H23NO5
    Molecular Weight 285.34 g/mol
    Cas Number 1326846-96-5
    Appearance Colorless to pale yellow oil
    Purity ≥ 95%
    Solubility Soluble in organic solvents (e.g., dichloromethane, ethyl acetate)
    Smiles CC(C)(C)OC(=O)C1COC(CN)(OC1(C)C)C#N
    Optical Activity [α]D +20° (c 1.0, CHCl3)
    Storage Temperature 2-8°C

    As an accredited tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The 5-gram quantity is supplied in a sealed amber glass bottle with a tamper-evident cap and clearly labeled with chemical details.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Securely packed sealed drums of tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate, palletized, maximizing container space.
    Shipping The chemical **tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate** should be shipped in tightly sealed containers, protected from light and moisture. It should be transported in accordance with local and international regulations, ideally by courier specialized in chemicals, and accompanied by proper safety and hazard documentation (SDS/MSDS).
    Storage Store **tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate** in a tightly sealed container, protected from light and moisture, in a cool, well-ventilated chemical storage area. Keep away from oxidizing agents, acids, and ignition sources. Ensure proper labeling and avoid prolonged exposure to air to prevent decomposition. Use appropriate personal protective equipment when handling.
    Shelf Life Shelf life: Store tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate cool, dry, and protected from light; typically stable for 2 years.
    Application of tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate

    Applications of tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate in Industrial Manufacturing

    As an experienced manufacturer, we supply tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate for a narrow range of specialized sectors where this intermediate supports stringent industrial processes and meets application-specific performance and compliance standards. Below, we detail its role in key downstream applications, including regulatory frameworks, integration points in production, dosage guidance, and resulting commercial product formats.

    1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient (API) Synthesis

    This compound primarily functions as a protected building block within multi-step synthesis of certain chiral pharmaceuticals. Formulators use it during the preparation of complex molecules, such as antidiabetic and antiviral drug candidates, where stereochemistry and purity are critical under GMP environments. Its reactivity and stability profile supports high-yield transformations while maintaining rigorous compliance for human health products.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Synthesis of Specialty Agrochemical Intermediates

    In agrochemical synthesis chains, this chemical provides a means to install stabilized, masked reactive groups necessary for developing functionalized pyridine or triazole compounds, particularly in new-generation selective herbicides or fungicides. The precise geometry and high purity enable formulating intermediates that contribute to selectivity and product shelf-life for environmentally regulated pesticide formulations.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Protected Building Block for Carbohydrate-Based Fine Chemicals

    Research and commercial synthesis of carbohydrate derivatives for diagnostics, fine chemical reagents, or modified sugars leverage this compound for its ability to stabilize labile centers while enabling specific downstream modifications. Its dioxane moiety ensures selectivity during glycosylation or deprotection processes, critical for purity in analytical and reagent end-use cases.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Fine Chemical Intermediate for Chiral Auxiliary Synthesis

    This material serves as a chiral auxiliary precursor in the preparation of highly specific auxiliaries for asymmetric synthesis. Downstream producers value its stereocontrolled dioxane architecture in advancing yield and enantioselectivity in manufacturing flavors, fragrances, and specialized polymer additives where precise conformation is essential for function.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) Acetate: Our Perspective as the Synthesis Team

    What Drives Our Approach in Developing this Advanced Intermediate

    In the complex world of advanced organic synthesis, one often encounters a turning point where reliable building blocks can define the success of multi-step projects. As a chemical manufacturer, our focus sits squarely on the challenges scientists face at the bench. Tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate stands out among our catalogue—born through persistent optimization of protection-deprotection protocols and refined handling of reactive cyanomethyl groups. The journey has given our teams a broad view of what sets this product apart, how it integrates into medicinal and materials research, and the subtle technical choices that impact real-world results.

    What We Have Learned in the Lab

    Years of process refinement revealed that purity stands as a silent barrier between a mediocre batch and a trusted staple for innovators downstream. Every operator on our floor understands the difference a half point of impurity may cause: failed reactions, inconsistent results, or even regulatory setbacks. By controlling every stage—from dioxane ring formation, strategic introduction of cyanomethyl, through precise acetate esterification—we deliver a tert-butyl intermediate that echoes the priorities set by teams needing to pass tight analytical scrutiny.

    Specification and Handling Come from Real Needs, Not Marketing Slides

    In our production plant, the specification for each batch reflects dialogue with synthetic chemists and process engineers. We moved away from "industry standard" guidelines long ago, instead listening to feedback about issues like moisture content, trace byproducts, and packaging needs. For this intermediate, the solution arrived as a crystalline solid, highly stable thanks to the dioxane ring, and non-hygroscopic, a detail often overlooked until a bottle sits open during a long synthesis run.

    With rigorous in-process control, our typical batch purity reaches 98.5% or greater by HPLC. Residual solvents and inorganic content falls well below 0.5%. The melting point range has been narrowed purposefully, providing users with a visual cue for product acceptance even before running chromatographic checks. The result comes from not just monitoring, but actively leveraging operator experience—spotting shifts in color or texture that suggest rework before dispatch.

    Understanding Its Role in Today’s Research Projects

    Applications of tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate head primarily into the world of medicinal chemistry, where the development timeline hinges on robust intermediate supply. In our direct conversations with researchers, this molecule’s dioxane protection and tailored cyanomethyl side chain offer selective reactivity. The cyanomethyl group introduces a differentiated electrophilic site, which is prized for coupling steps or further functionalization in the presence of sensitive motifs elsewhere on the scaffold.

    Another advantage arises from its bulky tert-butyl ester, giving chemists the control they seek for orthogonal protecting group strategies. The ability to reliably unfold specific steps without scrambling sensitive functionality saves weeks of time—sometimes more than any brand new reagent introduced each year.

    Not Just Another Dioxane Derivative: Differences Show in Practice

    On the surface, one could mistake this product as similar to several commercially offered dioxane-protected intermediates. Real differences emerge only at the workbench. Many products labeled “comparable” elsewhere fail to match the balance of stability and reactivity here. With our years of small-batch and scale-up work, we have seen how subtle flaws—excessive volatility, unreactive side products, or incomplete removal of isomeric impurities—put whole sequences in jeopardy.

    One persistent challenge comes from scale-up: intermediates produced under less-controlled conditions sometimes show unexpected instability, especially when stored or shipped across climate zones. We fine-tuned both solvent system and crystallization methods to yield a product with consistent shelf-life and minimal risk of decomposition. The dioxane ring, protected by tert-butyl and acetate groups, shields labile positions that would otherwise degrade, while still allowing the precise point of deprotection demanded later in synthetic sequences.

    In direct contrast to other protected cyanomethyl dioxanes, ours maintains stereochemical purity across multiple batches. On-the-ground, this means the enantiomeric excess remains well within the hard specs required for drug candidate tracking. Returns from partners suggest that, supported by our detailed NMR and chiral HPLC data, even the final step yields remain reliable—reducing lost time and waste.

    Working Hand-in-Hand with Our Customer Community

    We see every inquiry as a source of insight. Our technical support often fields questions around solvent choice, reaction compatibility, or storage needs. Based on real feedback, we tweaked our packaging to use moisture-protecting liners and smaller fill-size options, lowering the risk during sensitive synthetic stages or parallel library builds. Some partners have mentioned realizing major sequencing cost reductions just through fewer failed reactions or safer handling—outcomes that trace directly back to upstream supplier choices rather than new technologies on the market.

    In customer collaborations, a trend emerges: teams in pharmaceutical pipelines use tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate to support both hit-to-lead programs and more mature candidate scale-ups. They return to us not because of a slick brochure but because reaction outcomes match (and often exceed) their in-house standards. By keeping communication lines open, we pinpoint changes that actually matter—adjusting lot size, tightening specs, or providing custom analytical documentation for regulatory submission. These seemingly simple fixes often mean the difference between on-time project delivery and a missed milestone.

    Why Purity and Consistency Matter at Every Step

    As a critical intermediate, this product often enters multistep reaction sequences where accumulated side reactions can snowball into significant yields loss. In our own R&D pilot lines, introducing even minute levels of structural isomers or residual solvents led to time-consuming troubleshooting across late-stage steps. We invested in installation and qualification of analytical equipment not as a luxury, but because our team experienced the cost of impurity events in both time and materials.

    Every batch release meets not just core analytical checks, but also a suite of secondary controls: optical rotation for chiral confirmation, advanced GC for trace impurity accounting, and repeated stress-testing of thermal and humidity stability. These layers reflect years spent learning not from what’s easy to control, but from unexpected field failures that forced deeper process examination. The final outcome for our partners comes through in lower out-of-spec material returned, stronger IP protection, and a smoother review from regulatory authorities.

    Scale-Up Experience Shapes Each Decision

    Moving from gram to kilogram scale teaches lessons that bench chemistry never quite previews. Solvent recovery takes on new urgency, yields become more tightly watched, and storage conditions that seem forgiving at small scale become sources of trouble. Through all these transitions, our production chemists recorded challenges and solved them: minimizing water pickup post-crystallization, doubling down on line clearance checks, and validating secondary container reliability for shipments.

    In global supply chains, any stop-start rhythm ripples out as costly delays. We saw this directly during disruptions and material shortages, pushing our team to over-communicate with end users and prep contingency supply wherever possible. Product quality depends not just on the immediate synthesis but on how each drum or bottle survives customs, transit, and long-term storage at university or pilot facilites. Maintaining tight cGMP-style logs—even for research-grade products like this—cuts the risk of undetected batch deviations and supports traceability when needed.

    Beyond the Lab: End Uses and Industry Impact

    The dominant end user group for this intermediate comes from research-driven companies focused on drug design. With growing demand for complex, stereochemically defined scaffolds, we see usage in both combinatorial library construction and targeted functionalizations for CNS, oncology, and metabolic disease programs. The tert-butyl and dioxane elements give practical flexibility for both protection and measured deprotection, enabling chemists to introduce further functional groups without backtracking.

    Outside pharmaceutical synthesis, material scientists and process chemists explore its use in polymerizable side chains, or in developing new ligands for asymmetric catalysis. We hear from both ends of this spectrum: small research groups experimenting with reactivity, and industrial process teams demanding batch-after-batch reproducibility. Their feedback ensures that the product continues to fit evolving scientific trends rather than sitting static as a commodity for resale.

    Minimizing Risk, Maximizing Project Outcomes

    Our collective experience points to a simple truth: every intermediate must reduce risk, not just check boxes for purity or availability. With this dioxane-acetate, paying attention to the real-world hurdles—product clumping, seasonal humidity swings, shifting analytical requirements—makes or breaks projects. That’s why we have built out not just QA, but tiered support that connects researchers directly with synthesis chemists or quality leads. Every improvement in specification, packaging, or documentation stems from this unbroken chain of problem-solving.

    We remain open to customer-driven process changes. An example arose early on: a partner flagged residual catalyst carryover just above their threshold, so the team responded with an updated purification protocol. The solution did not stem from a theoretical exercise, but from sharing analytic data, root-cause investigation, and timely feedback cycles. This culture—born on the production floor, carried through every bottling and shipment—anchored us through changing regulatory guidelines and shifting research demands.

    Supporting Advanced Research Through Reliable Supply

    The trust our partners place in this intermediate comes from years of operating as a direct producer—not a distributor or repackager. Every lot brings lessons, not just in technical chemistry but in communication, shipment logistics, and the quietly critical world of regulatory paperwork. Supply chain security matters just as much as analytical detail when researchers plan their next campaign. Keeping our internal and external records seamless ensures contingencies are already in place should a shipment require rerouting or expedited release.

    While the core chemistry demonstrates stability and selectivity, the infrastructure backing each product line amplifies its practical benefit. Automated batch records, stringent environmental controls, and careful technician oversight all serve a purpose: enabling research teams to focus on innovation without troubleshooting background supply issues. Even for specialty intermediates such as tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate, the expectation now falls on source manufacturers to preempt potential project hurdles—not just respond to them.

    Continual Improvement in Sync With Evolving Science

    From synthetic methodology trends to advanced regulatory expectations, the science surrounding our products shifts every year. We track not only published work but also confidential client feedback on emerging needs: demand for lower trace metal contamination, increasingly stringent optical purity, or packaging that withstands both cold chain and ambient exposure. By treating every batch as a learning opportunity, our teams stay on the cusp of what’s next, not just what worked before.

    Making small, informed changes—like reducing the packaging size for high-throughput screening users or validating improved recycling protocols—translates to direct value for end users. Commitment to continuous improvement links production chemists, QA, and front-line support in a loop that strives not just for compliance but for best-in-class performance.

    Our Take on the Role of Tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate in Modern Chemistry

    This intermediate has proven a linchpin in numerous research settings because it pairs robust protection strategy with a versatile electrophilic handle. The dioxane core, accentuated by cyanomethyl and tert-butyl acetate, places it in an elite class of building blocks flexible enough for mainstream pharmaceutical synthesis yet stable enough to support long-term storage and scale-up campaigns.

    Customers seeking just a “box-checked” intermediate may well get by with lower spec or less-consistent alternatives, but those running multi-million dollar development programs cannot afford preventable downtime or analytical surprises. Detailed feedback loops, grounded in honest process reviews, keep our standards higher. By speaking directly to the bench-level frustrations and regulatory challenges faced by end users, we remain accountable to those investing in innovation rather than turnover.

    Moving forward, new projects may refine our own synthesis routes, adopt greener solvents, or borrow process innovations from adjacent fields. Each change emerges not from external pressure, but from the conviction that every tone improvement in product consistency, ease-of-use, or documentation can cascade through the entire research chain—accelerating outcomes and reducing overall cost. Tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate, as produced here, reveals what technical diligence and open communication can do for research chemistry.

    Commitment to Transparent, Experience-Driven Supply

    Our legacy as a manufacturer comes from direct engagement with the realities of process chemistry. The teams adapting a protocol in a university lab, or managing a candidate scale-up in a pilot facility, rely on intermediates that do not introduce more uncertainty into the workflow. Every decision—crystallization method, packaging upgrade, control-point documentation—reflects both repeated testing and a willingness to admit mistakes, share knowledge, and act fast where challenges emerge.

    By anchoring our understanding of market demands in this shared experience, we aim to provide products that simplify, not complicate, advanced synthesis and material innovation. We invite research partners to join this ongoing dialogue, both to share pain points and define future solutions. Through every lot of tert-butyl 2-((4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate that leaves our facility, our commitment to collaboration, quality, and progress manifests in a form researchers trust.